Evidence map›Paper›PMID 38161508›Full record

ArticleMaterials today. Bio2023

Photo-crosslinked bioactive BG/BMSCs@GelMA hydrogels for bone-defect repairs.

Yufeng Ai, Fang Dai, Wenfeng Li, Fancheng Xu, Hanwen Yang, Jianxin Wu, Kaiqiang Yang, Li Li, Fanrong Ai, Li Song

Open access · goldAbstract read
In one paragraph

Article in Materials today. Bio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yufeng AiCenter of Stomatology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 33006, China.
Fang DaiCenter of Stomatology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 33006, China.
Wenfeng LiCenter of Stomatology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 33006, China.
Fancheng XuCenter of Stomatology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 33006, China.
Hanwen YangThe Second Clinical Medical School, Nanchang University, Nanchang, Jiangxi, 33006, China.
Jianxin WuCenter of Stomatology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 33006, China.
Kaiqiang YangCenter of Stomatology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 33006, China.
Li LiCenter of Stomatology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 33006, China.
Fanrong AiSchool of Advanced Manufacturing, Nanchang University, Nanchang, Jiangxi, 33006, China.
Li SongCenter of Stomatology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 33006, China.
Nanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clinical treatments of bone defects remain a challenge. Hydrogels containing bone marrow mesenchymal stem cells (BMSCs) are extensively used to bone regeneration because of excellent biocompatibility and hydrophilicity. However, the insufficient osteo-induction capacity of the BMSC-loaded hydrogels limits their clinical applications. In this study, bio-active glass (BG) and BMSCs were combined with gelatin methacryloyl (GelMA) to fabricate composite hydrogels via photo-crosslinking, and the regulation of bone regeneration was investigated. In vitro experiments showed that the BG/BMSCs@GelMA hydrogel had excellent cytocompatibility and promoted osteogenic differentiation in BMSCs. Furthermore, the BG/BMSCs@GelMA hydrogel was injected into critical-sized calvarial defects, and the results further confirmed its excellent angiogenetic and bone regeneration capacity. In addition, BG/BMSCs@GelMA promoted the polarization of macrophages towards the M2 phenotype. In summary, this novel composite hydrogel demonstrated remarkable potential for application in bone regeneration due to its immunomodulatory, excellent angiogenetic as well as osteo-induction capacity.

Indexed as

Bio-active glassBMSCsBone regenerationGelMA

Identifiers

PMID38161508
PMCPMC10755535
OpenAlexW4389396343

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.